329 related articles for article (PubMed ID: 31507606)
1. Roles of Factor XII in Innate Immunity.
Renné T; Stavrou EX
Front Immunol; 2019; 10():2011. PubMed ID: 31507606
[TBL] [Abstract][Full Text] [Related]
2. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
3. Factor XII and uPAR upregulate neutrophil functions to influence wound healing.
Stavrou EX; Fang C; Bane KL; Long AT; Naudin C; Kucukal E; Gandhi A; Brett-Morris A; Mumaw MM; Izadmehr S; Merkulova A; Reynolds CC; Alhalabi O; Nayak L; Yu WM; Qu CK; Meyerson HJ; Dubyak GR; Gurkan UA; Nieman MT; Sen Gupta A; Renné T; Schmaier AH
J Clin Invest; 2018 Mar; 128(3):944-959. PubMed ID: 29376892
[TBL] [Abstract][Full Text] [Related]
4. Factor XII in inflammation and wound healing.
Stavrou EX
Curr Opin Hematol; 2018 Sep; 25(5):403-409. PubMed ID: 29994899
[TBL] [Abstract][Full Text] [Related]
5. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
7. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
8. Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
Long AT; Kenne E; Jung R; Fuchs TA; Renné T
J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513
[TBL] [Abstract][Full Text] [Related]
9. The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity.
Weidmann H; Heikaus L; Long AT; Naudin C; Schlüter H; Renné T
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2118-2127. PubMed ID: 28743596
[TBL] [Abstract][Full Text] [Related]
10. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
11. An update on factor XII-driven vascular inflammation.
Mailer RK; Rangaswamy C; Konrath S; Emsley J; Renné T
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119166. PubMed ID: 34699874
[TBL] [Abstract][Full Text] [Related]
12. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
Schmaier AH
J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
[TBL] [Abstract][Full Text] [Related]
13. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activity of contact factor zymogens.
Shamanaev A; Emsley J; Gailani D
J Thromb Haemost; 2021 Feb; 19(2):330-341. PubMed ID: 33107140
[TBL] [Abstract][Full Text] [Related]
15. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
[TBL] [Abstract][Full Text] [Related]
16. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
17. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
Schousboe I; Nystrøm BT; Hansen GH
FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
19. A nanobody-based method for tracking factor XII activation in plasma.
de Maat S; van Dooremalen S; de Groot PG; Maas C
Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
[TBL] [Abstract][Full Text] [Related]
20. Protease activity in single-chain prekallikrein.
Ivanov I; Verhamme IM; Sun MF; Mohammed B; Cheng Q; Matafonov A; Dickeson SK; Joseph K; Kaplan AP; Gailani D
Blood; 2020 Feb; 135(8):558-567. PubMed ID: 31800958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
